Back to search

Article

Exploring the synergistic behaviour of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management

2023-05-24

Abstract excerpt

<title>Abstract</title> <p>Breast cancer is challenging to treat accompanied with poor clinical outcomes. Paclitaxel (PTX) is a first-line chemotherapeutic agent, but possesses limitations due to side effects, high dose, non-specific tissue distribution, and drug resistance. An epigenetic modulator, Vorinostat (VOR) is known to enhance PTX efficacy and therefore to resolve the issues of conventional PTX formulati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b00bb165-4781-500f-acd1-d8ed82593567
DOI
10.21203/rs.3.rs-2928600/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the synergistic behaviour of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer managementDOI 10.21203/rs.3.rs-2928600/v1
Select a neighboring publication to make it the new centre.